KRMD
KORU Medical Systems, Inc. Common Stock (DE)
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
KRMD Stock Analysis: Buy, Sell, or Hold?
$3.69
-0.20 (-5.14%)
βΌ
5d:
+21.78%
30d:
+18.65%
90d:
+8.53%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (18%)
Quality Score
34/100
Position
EXTENDED
30-Day Fair Range
$2.93 β $3.33
Position: EXTENDED
Forward P/E & Valuation
184.5x
STRETCHED
vs 155.2x historical avg
Wall Street Target
$6.13
+66.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.92 / $4.07
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
βΈοΈ WAIT FOR BETTER ENTRY: KRMD is 10.8% above its trading range ($3.33). Market expects 5.9% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Get Alerted When KRMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: KRMD is currently trading at $3.69, which is considered extended relative to its 30-day fair value range of $2.93 to $3.33. From a valuation perspective, the stock is trading at a premium (Forward PE: 184.5) compared to its historical average (155.2). At these levels, the market is pricing in 5.9% annual earnings growth.
Technical Outlook: Technically, KRMD is in a strong downtrend. Immediate support is located at $2.92, while resistance sits at $4.07. Short-term momentum is weak, with the stock down 5.1% recently.
Market Sentiment: KRMD scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.12 (+66.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KRMD is in a strong downtrend. Immediate support is located at $2.92, while resistance sits at $4.07. Short-term momentum is weak, with the stock down 5.1% recently.
Market Sentiment: KRMD scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $6.12 (+66.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.93 -
$3.33
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
17.6%
Trading Range & Key Levels
30-Day Trading Range
$2.93 -
$3.33
Current vs Trading Range
EXTENDED
Support Level
$2.92
Resistance Level
$4.07
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BEARISH: Price significantly overextended (+10.8% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.1%)
- BULLISH: Trading 66.0% below Wall St target ($6.12)
- BULLISH: Expecting earnings turnaround to 5.9% growth with 11.2% revenue growth
- WARNING: Composite score 34/100 in the bottom quintile β this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
184.50
Wall Street Target
$6.13
(+66.0%)
Revenue Growth (YoY)
11.2%
Earnings Growth (YoY)
-66.0%
Profit Margin
-1.8%
Valuation Premium vs History
+5.9% premium
PE vs Historical
184.5 vs 155.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.9%
(market-implied from PE analysis)
1-Year Target
$3.91
(+6%)
2-Year Target
$4.14
(+12%)
3-Year Target
$4.38
(+19%)
3-Yr Target (if PE normalizes)
(PE: 185β155)
PE COMPRESSION
$3.69
(0%)
Earnings growth offset by PE compression
Share KRMD Analysis
Share this live KRMD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (KRMD)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 1, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages indicate bullish sentiment towards $KRMD with one user expressing confidence in the stock price stabilizing and potentially testing lower prices that were previously seen. No recent news articles were found.
Key Retail Themes:
Bullish sentiment towards $KRMD
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 5:40 PM ET
Data refreshes hourly during market hours. Next update: 6:40 PM
Data refreshes hourly during market hours. Next update: 6:40 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KRMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$486 | 39 SELL |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$82 | 44 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
21 analysts |
$203 | 55 HOLD |
|
WST
West Pharmaceutical Serv⦠|
STRONG BUY
16 analysts |
$471 | 42 HOLD |
|
RMD
ResMed Inc |
HOLD
20 analysts |
$264 | 58 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive KRMD Research Pages